Meitav Investment House’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,597
| Closed | -$63.8K | – | 446 |
|
|
2023
Q2 | $63.8K | Buy |
+1,597
| New | +$63.8K | ﹤0.01% | 420 |
|
|
2023
Q1 | – | Sell |
-17,475
| Closed | -$841K | – | 370 |
|
|
2022
Q4 | $841K | Hold |
17,475
| – | – | 0.01% | 258 |
|
|
2022
Q3 | $634K | Hold |
17,475
| – | – | 0.01% | 273 |
|
|
2022
Q2 | $482K | Sell |
17,475
-95,644
| -85% | -$2.64M | 0.01% | 277 |
|
|
2022
Q1 | $6.15M | Sell |
113,119
-24,517
| -18% | -$1.33M | 0.09% | 146 |
|
|
2021
Q4 | $8M | Hold |
137,636
| – | – | 0.13% | 129 |
|
|
2021
Q3 | $5.45M | Buy |
+137,636
| New | +$5.45M | 0.09% | 155 |
|